يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Krop ED"', وقت الاستعلام: 0.95s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية

    المؤلفون: Cai WL; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, United States.; Department of Pathology, Yale University, New Haven, United States., Chen JF; Department of Pathology, Yale University, New Haven, United States., Chen H; Department of Pathology, Yale University, New Haven, United States., Wingrove E; Department of Pathology, Yale University, New Haven, United States., Kurley SJ; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, United States., Chan LH; Department of Pathology, Yale University, New Haven, United States., Zhang M; Department of Pathology, Yale University, New Haven, United States., Arnal-Estape A; Department of Pathology, Yale University, New Haven, United States.; Yale Cancer Center, Yale School of Medicine, New Haven, United States., Zhao M; Department of Pathology, Yale University, New Haven, United States., Balabaki A; Department of Pathology, Yale University, New Haven, United States., Li W; Yale Cancer Biology Institute, Department of Pharmacology, Yale University, West Haven, United States., Yu X; Mount Sinai Center for Therapeutics Discovery, Icahn School of Medicine at Mount Sinai, New York, United States.; Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States., Krop ED; Department of Pathology, Yale University, New Haven, United States.; Department of Biosciences, Rice University,, Houston, United States., Dou Y; Department of Pathology, University of Michigan, Ann Arbor, Ann Arbor, United States.; Department of Medicine, Department of Biochemistry and Molecular Medicine, University of Southern California, Los Angeles, United States., Liu Y; Yale Cancer Center, Yale School of Medicine, New Haven, United States.; Yale Cancer Biology Institute, Department of Pharmacology, Yale University, West Haven, United States., Jin J; Mount Sinai Center for Therapeutics Discovery, Icahn School of Medicine at Mount Sinai, New York, United States.; Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States., Westbrook TF; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, United States., Nguyen DX; Department of Pathology, Yale University, New Haven, United States.; Yale Cancer Center, Yale School of Medicine, New Haven, United States.; Yale Stem Cell Center, Yale School of Medicine, New Haven, United States.; Department of Internal Medicine (Section of Medical Oncology), Yale School of Medicine,, New Haven, United States., Yan Q; Department of Pathology, Yale University, New Haven, United States.; Yale Cancer Center, Yale School of Medicine, New Haven, United States.; Yale Stem Cell Center, Yale School of Medicine, New Haven, United States.; Yale Center for Immuno-Oncology, Yale School of Medicine, New Haven, United States.

    المصدر: ELife [Elife] 2022 Aug 31; Vol. 11. Date of Electronic Publication: 2022 Aug 31.

    نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

    بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE

  3. 3
    دورية أكاديمية

    المؤلفون: Gil Del Alcazar CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Trinh A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Alečković M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Rojas Jimenez E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Harper NW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Oliphant MUJ; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Xie S; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Krop ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lulseged B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Murphy KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Keenan TE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute, Cambridge, Massachusetts., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute, Cambridge, Massachusetts., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute, Cambridge, Massachusetts., Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Dillon DA; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Pathology, Harvard Medical School, Boston, Massachusetts., Muthuswamy SK; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute, Cambridge, Massachusetts.; Harvard Stem Cell Institute, Cambridge, Massachusetts.

    المصدر: Cancer immunology research [Cancer Immunol Res] 2022 Jun 03; Vol. 10 (6), pp. 680-697.

    نوع المنشور: Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Journal Article; Comment

    بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE